Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 30, 2018 - Issue 7-8
130
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Mesenchymal stem cells overexpressing Ang1 attenuates phosgene-induced acute lung injury in rats

, , &
Pages 313-320 | Received 19 May 2018, Accepted 05 Sep 2018, Published online: 05 Nov 2018
 

Abstract

Phosgene-induced acute lung injury (P-ALI) is characterized by inflammation and effective treatments are lacking. Angiopoietin-1 (Ang1) has the beneficial effects on P-ALI. Mesenchymal stem cells (MSCs) have the potential for re-epithelization and recovery in lung injury. Thus, we hypothesized that Ang1 expressing MSCs would have beneficial effects on P-ALI. Here, an Ang1 expressing lentiviral vector was constructed and infected into rat bone marrow MSCs. Histological analyses revealed significant pathological improvements especially after treatment with MSCs in the rats exposed to phosgene. Ang1 facilitated the homing of MSCs to injured lung tissue and significantly increased expression of both epithelial cell marker Aquaporin-5 (AQP5) and surfactant protein-C (SPC) in the lung tissues. Moreover, MSCs-Ang1 reduced level of pro-inflammatory cytokines TGF-β1 and IL-1β and increased the expression of the anti-inflammatory cytokine IL-10 in the serum and bronchoalveolar lavage fluid (BALF) of P-ALI rats. In conclusion, our results suggest that Ang1 may improve the therapeutic potential of MSCs for P-ALI treatment.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was funded by the National Natural Science Foundation of China (81471850) and the Jinshan District Health and Family Planning Commission-Training program for outstanding young people (JSYQ201602).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.